InicioGETI-B • STO
add
Getinge AB
Cierre anterior
218,50 kr
Intervalo diario
216,40 kr - 221,20 kr
Intervalo anual
174,85 kr - 240,20 kr
Cap. bursátil
56,15 mil M SEK
Volumen medio
678,60 mil
Relación precio-beneficio
22,96
Rentabilidad por dividendo
2,02 %
Bolsa de valores principal
STO
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (SEK) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos | 8305,00 M | 15,73 % |
Gastos operativos | 2989,00 M | 12,45 % |
Ingresos netos | 513,00 M | 139,72 % |
Margen de beneficio neto | 6,18 | 107,38 % |
Beneficios por acción | 2,29 | 110,09 % |
EBITDA | 1184,00 M | 69,38 % |
Tipo impositivo efectivo | 26,71 % | — |
Balance general
Activos totales
Responsabilidades totales
| (SEK) | jun 2024info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 2286,00 M | -48,44 % |
Activos totales | 55,23 mil M | 4,52 % |
Responsabilidades totales | 23,53 mil M | 9,24 % |
Patrimonio total | 31,70 mil M | — |
Acciones en circulación | 272,37 M | — |
Precio-valor contable | 1,89 | — |
Rentabilidad económica | 4,13 % | — |
Retorno sobre capital | 5,67 % | — |
Flujo de caja
Variación neta del flujo de caja
| (SEK) | jun 2024info | Cambio interanual |
|---|---|---|
Ingresos netos | 513,00 M | 139,72 % |
Efectivo de operaciones | 609,00 M | -6,16 % |
Efectivo de inversión | -616,00 M | -22,71 % |
Efectivo de financiación | -1038,00 M | -220,37 % |
Variación neta del flujo de caja | -1072,00 M | -461,26 % |
Flujo de caja libre | 121,00 M | 11,14 % |
Información sobre la empresa
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. The company was formerly organised in three business areas: Infection Control, Extended Care and Medical Systems, but announced it would become a single brand company, operating under the brand Getinge, on 20 March 2017.
In 1989, it was acquired by Rune Andersson and Carl Bennet. Getinge’s stocks have been noted on the Stockholm stock exchange since 1993 and have been part of the OMXS30 Index since July 2009.
The company's president and CEO is Mattias Perjos. Johan Malmquist is the company's chairman. Getinge's shares have been listed on the OMX Nordic List in Stockholm since 1993 and have formed part of the OMXS30 index since July 2009. In 2011 Getinge acquired the US company Atrium Medical and in 2014 Pulsion Medical Systems. Wikipedia
Director ejecutivo
Fundación
1904
Sitio web
Empleados
11.891
